about
The role of iron and haemochromatosis gene mutations in the progression of liver disease in chronic hepatitis CCirrhosis with steatohepatitis after adjuvant tamoxifenScoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage inFrequency of early colorectal cancer in patients undergoing colonoscopy.Cytomegalovirus pouchitis in a patient with Crohn's disease.Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelEpigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.Targeting mTOR dependency in pancreatic cancerNon-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivoEradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatmentCo-amoxiclav jaundice: clinical and histological features and HLA class II association.Hepatic granulomas: a 10 year single centre experience.SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients.Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy.Hunting the primary: novel strategies for defining the origin of tumours.Loss of MSH2 protein expression is a risk factor in early stage cervical cancerAmpullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.Effusion cytology of hepatocellular carcinoma with in situ hybridisation for human albumin.Cancers of unknown primary diagnosed during hospitalization: a population-based study.Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes.Clinical potential of microRNAs in pancreatic ductal adenocarcinoma.Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.Acute WNT signalling activation perturbs differentiation within the adult stomach and rapidly leads to tumour formationTranslation efficiencies of the 5'-untranslated region of genotypes 1a and 3a in hepatitis C infected patients.Improvement of parenteral nutrition-associated cholestasis in an adult using fish oil-based parenteral nutritionDrug- not carrier-dependent haematological and biochemical changes in a repeated dose study of cyclosporine encapsulated polyester nano- and micro-particles: size does not matter.A Glasgow Tipple-transjugular intrahepatic portosystemic shunt insertion prior to Whipple resectionPrevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus.Cirrhosis with steatohepatitis following longterm stilboestrol treatment.Pneumocystis carinii pneumonia in a patient with rheumatoid arthritis, not on immunosuppressive therapy and in the absence of human immunodeficiency virus infection.Hypermutation In Pancreatic Cancer.Morphomolecular pathology: setting the framework for a new generation of pathologists.Gastrokine 1 is abundantly and specifically expressed in superficial gastric epithelium, down-regulated in gastric carcinoma, and shows high evolutionary conservation.Time for change: a new training programme for morpho-molecular pathologists?The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinoma.A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma.Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm.Acquired abnormalities of the biliary tract from chronic gallstone disease.Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
P50
Q28344953-0E161A8E-2763-43D9-8A64-1FBA14B385ACQ28369832-57B39C6B-E852-4A6D-BFA2-DAF3B9868E6CQ33710045-86D61E74-FF9B-434C-947F-B361B1F205CEQ33762488-574EFD6B-8371-4AAE-AA60-C59AF993CF2DQ33955968-9EBA583D-2442-4B11-9E78-D467603E3102Q33957368-FADDF78A-6E60-44C7-94E2-969C9BEA3905Q34028615-B7EA4E9E-0EC3-4156-940F-35E10BE9C08CQ34092334-F8995C75-5314-45A9-9E3F-32801D07D462Q34795935-0DC09AD3-EE81-4F23-9F4C-489DA7B40163Q35080479-B544783B-383C-484B-83BA-8F16592325F4Q35349400-2FA9182B-5CD7-4F26-8B66-62DC8FF97275Q35361803-C3B559AE-B8F3-4417-AC53-10BC03EFBED7Q35576620-99E3B989-1AC9-4AAC-9D23-03457F30E10AQ35677046-D5DC3C2B-4F2B-4784-B857-E8F6AA5FBA96Q36000813-D36752BA-A2FF-42F7-BD03-4BE5587495D7Q36004709-10229211-3E8E-481F-8EDB-F28655302E5CQ36017195-8481DDBD-318E-49C4-8C80-E0546B80D940Q37170296-FD8775EB-5D4E-4A27-BBD2-4956FE793437Q37208298-D9AF6214-C17B-4064-91EE-4062BB6EE808Q37615982-AA3B62C9-E405-4F1C-8F1F-8BC78FE7AA65Q37895027-DEBB2198-6443-431E-AEE5-6482C31C79D6Q37946163-CDEFCD9F-91BF-4515-9528-9AF1E753D626Q39811833-07E4273B-840D-4E80-BC11-0DD53425964FQ39969056-DE93DE38-E909-4B6A-8E72-71CD94B1A5DFQ40179726-FB1D454F-C09D-46EE-AFE8-AFF1374655F0Q41060537-29CE0238-5304-4AC0-AA7A-503B27D2CD10Q41502719-92E7B887-C78B-4534-ABA7-CBC8FA458DBAQ41518043-BDE48557-64A3-4802-8858-6159BC372D08Q42567431-F3EB7626-2B9A-4796-B262-64DD394C7262Q43011051-42A1B067-C89A-4962-9455-B1F22611A050Q45787248-CF13D32F-01BE-494E-92D2-2835675C6F3FQ46267270-D6D28C84-458C-45A1-AAE3-F3A62E643EB1Q47172639-F77817F5-17E8-401A-8F69-5CB4950FC320Q47278800-A061E910-9409-4CB7-BEFD-CDFF086DB911Q47637197-285B2307-D458-488D-8989-C8934AB48297Q47813408-EAE264D6-C6D5-4762-B48E-A844B50EC9A1Q48207504-2390D111-BAAC-4FCB-A0C9-7AA9E7C164B7Q50131280-68F578C7-8A49-4D74-BA7C-643C1D0D3D60Q50191311-09A00247-A753-4D51-A1AC-BD7E59A4B04DQ51320597-8CF1FF36-1561-4072-92FE-4B73A8C9D927
P50
description
researcher
@en
wetenschapper
@nl
name
K A Oien
@en
K A Oien
@nl
type
label
K A Oien
@en
K A Oien
@nl
prefLabel
K A Oien
@en
K A Oien
@nl
P106
P31
P496
0000-0002-5237-275X